Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia. - Zhang, Jie; Wu, Wenxuan; Wang, Yun; Zhang, Youping; Wang, Yingying; Bai, Wenhui; Zhang, Zhenge; Zhu, Chujiao; Wu, Yunzhao; Zhang, Ziwei; Yang, Li; Lei, Hu; et al. (Acta biochimica et biophysica Sinica, 2026)